Guidelines for diagnosis and treatment of HIV/AIDS in China (2005)

Chinese Medical Journal

Volumn 119, Issue 19, 2006, Pages 1589-1608

  Li, Tai Sheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMPHOTERICIN B; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; FOLINIC ACID; FOSCARNET SODIUM; GANCICLOVIR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; ISONIAZID; MEPREDNISONE; PENTAMIDINE; PREDNISONE; PRIMAQUINE; PYRAZINAMIDE; PYRIMETHAMINE; RIFAMPICIN; RIFAPENTINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN; SULFADIAZINE; TRIMETHOPRIM; UNINDEXED DRUG;

ABDOMINAL DISCOMFORT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ANTIBODY DETECTION; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANDIDIASIS; CENTRAL NERVOUS SYSTEM DISEASE; CHINA; CLINICAL FEATURE; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIZZINESS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; ELECTROLYTE DISTURBANCE; EPIDEMIOLOGICAL DATA; FATTY LIVER; FUNGAL MENINGITIS; GASTROINTESTINAL SYMPTOM; GOUT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION PREVENTION; INSOMNIA; KIDNEY DYSFUNCTION; LABORATORY TEST; LACTIC ACIDOSIS; LATERAL BRAIN VENTRICLE; LEUKOPENIA; LIVER TOXICITY; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; NAUSEA; NEPHROTOXICITY; NEURITIS; NEUTROPENIA; NONHUMAN; OPPORTUNISTIC INFECTION; OPTIC NEURITIS; OTOTOXICITY; PANCREATITIS; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; SURGICAL DRAINAGE; THROMBOCYTOPENIA; TOXOPLASMOSIS; VESTIBULAR DISORDER; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; VOMITING; VULNERABLE POPULATION;

EID: 33750045145     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200610010-00002     Document Type: Article

References (18)

1. Levy JA. HIV and the pathogenesis of AIDS. 2nd ed. Washington DC: ASM Press; 1988: 27-40.
2. Zhang XQ, Fan J. HIV infection and AIDS. Beijing: People's Medical Publishing House; 1999: 230-246.
3. Barre-Sinoussi F, Chermann JC, Rey MT, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868-871.
4. Graf M, Shao Y, Zhao Q, Seidl T, Kostler J, Wolf H, et al. Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses 1998; 14: 285-288.
5. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-673.
6. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995; 333: 751-756.
7. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-126.
8. + T cell homeotasis and function in advanced HIV disease. Science 1997; 277: 112-116.
9. Loachim HL. Pathology of AIDS. Philadelphia: J.B.Lippincott Company; 1989: 25-75.
10. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41(RR-17): 1-19.
11. World Health Organization. Clinical aspects of HIV/AIDS. New Delhi: WHO Regional Office for South-East Asia; 2002: 3-25.
12. Daar E, Little S, Pitt J, Santangelo J, Ho P, Harawa N, et al. Diagnosis of primary HIV-1 infection. Ann Intern Med 2001; 134: 25-29.
13. O'Neill JF, Seluyn PA, Schietinger H. Assessment of physical symptoms. A clinical guide to supportive and palliative care for HIV/AIDS. Washington DC: US Department of Health and Human Services, 2003. (Accessed July 5, 2006 at http://www.ask.hrsa.gov/HIV.cfn).
14. State Bureau of Technical Supervision. National Standard of the People's Republic of China. Diagnostic criteria and management principles of HIV/ AIDS (1995): 215.
15. Grirard PM, Katlama C, Pialoux G, eds. VIH. Paris: DOIN Edition; 2001: 77-144.
16. US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infect Dis Obstet Gynecol 2002; 10: 3-64.
17. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004; 292: 251-265.
18. Centers for Disease Control and Prevention, U.S. Public Health Service Task Force. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep 2002; 51(RR-18): 1-38.